# Cambridge Cognition wins new £750,000 digital health contract

- Link: https://www.directorstalkinterviews.com/cambridge-cognition-wins-new-750000-digital-health-contract/412862879
- Published: 2020-10-07T07:31:08+01:00
- Author: Giles Arbor

**Cambridge Cognition Holdings plc** ([LON:COG](https://www.directorstalkinterviews.com/company/cambridge-cognition-holdings-plc/cog.l)),
which develops and markets digital solutions to assess brain health, has announced
that it has won a new contract providing cognitive tests and electronic clinical
outcome assessments for an Alzheimer’s trial. The total Contract is worth approximately
£750,000 over two years, with a considerable proportion of the revenue for the Company
expected to be received in 2021.

Alzheimer’s trials have seen significant disappointments in recent years, so this
pharmaceutical client is taking a new approach with a cutting-edge part-virtual 
clinical trial which combines in-person and remote testing. Cambridge Cognition 
is in a unique position to support the delivery of this trial with expertise in 
both gold-standard cognitive assessment and innovative digital health solutions 
for frequent, remote testing.

To establish the cognitive impact of the drug, patients will complete CANTAB^(TM)
cognitive assessments both in clinic and at home. The Company will also capture 
the important caregiver perspective by deploying an engaging mobile application.
To deliver the Contract, Cambridge Cognition will configure existing modules developed
for previous clinical trials rather than undertaking bespoke software development.

> **Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:**
> “We are delighted to be supporting the continuing pursuit of a new Alzheimer’s
> therapeutic with all three of our major commercial solutions: CANTAB™ cognitive
> assessments, eCOA questionnaires, and digital health applications. The disease
> burden for caregivers and family members cannot be overlooked and so we are particularly
> excited to play such an active role in capturing their experience for the trial.”

Share on: